How to Interpret the GI360™

Presented by Jeannie Gorman, MS, CCN | August 7, 2024 If your patients suffer from gastrointestinal issues like IBS or IBD, systemic conditions such as celiac disease, cardiovascular or neurological disorders, and even skin or autoimmune diseases, the GI360™ from Doctor's Data could be a game-changer.This webinar will provide an overview of the industry-leading GI360™ stool test. A primary focus will be the rationale for the essential incorporation of complementary methodologies to evaluate gastrointestinal microbes. Other components covered will be the advantages and limitations of PCR-based testing, culture-based/proteomic testing, and susceptibility testing. Additionally, the highly focused microbiome and dysbiosis evaluation will be highlighted regarding published validation and clinical application. Furthermore, the comprehensive array of stool chemistries will be featured in context with the overall evaluation. Case studies will also be presented to illustrate the clinical value of the GI360™. Learning Objectives: • Jeannie Gorman, MS, CCN, will explain the test's utilization of advanced technologies like multiplex PCR, MALDI-TOF, and microscopy. • You will learn how the GI360™ informs the Dysbiosis Index (DI) and Diversity Score (DS) and what these scores mean for your patients. • You will get practical advice on the stool sample collection process and learn why PCR testing's sensitivity is crucial for accurate results.) • Plus, tips on follow up testing!Whether you're a healthcare professional or someone interested in gut health, this webinar offers invaluable insights into interpreting the GI360™ test and applying its findings for better health outcomes. CHAPTERS: 00:00 GI 360 Overview & Objectives 01:03 Clinical Uses of GI Testing 03:44 Ideal Candidates for Gut Testing 05:09 When to Avoid Testing 07:02 Proper Stool Collection Guidelines 08:59 PCR and Culture Methodologies Explained 10:59 Benefits of PCR vs Culture 13:03 Understanding the GI 360 Report 14:53 Disbiosis Index & Diversity Score 16:13 Functional Guilds and Key Findings 17:07 Deep Dive into Beneficial Microbiome 18:47 Important Microbiota Species Explained 20:07 Transition to Pathogen Detection 21:20 Parasitology and Yeast Findings 22:11 Culture Analysis and Dysbiotic Bacteria 23:40 Stool Chemistry and Short Chain Fatty Acids 25:17 Natural & Rx Treatment Options 27:12 Case Study: Female with Chronic Diarrhea 30:29 Interpretation of Microbiome Imbalances 33:05 Inflammation, Immune Markers & Short Chain Fatty Acids 36:04 Treating Candida and Dysbiosis 38:01 Custom Treatment Plan & Retesting 40:00 Patient Recommendations & Dietary Adjustments 42:04 Q&A Session Begins